Atika Capital Management LLC - Q3 2019 holdings

$475 Million is the total value of Atika Capital Management LLC's 146 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was 46.8% .

 Value Shares↓ Weighting
XBI SellSPDR SERIES TRUSTput$18,185,000
-15.4%
238,500
-2.7%
3.83%
-9.3%
ROKU SellROKU INC$11,600,000
-3.0%
114,000
-13.6%
2.44%
+4.0%
KMX SellCARMAX INC$11,176,000
-14.2%
127,000
-15.3%
2.35%
-8.0%
OKTA SellOKTA INCcl a$9,846,000
-46.9%
100,000
-33.3%
2.07%
-43.0%
EXAS SellEXACT SCIENCES CORP$9,037,000
-43.4%
100,000
-26.1%
1.90%
-39.4%
ARNA SellARENA PHARMACEUTICALS INC$8,284,000
-38.6%
181,000
-21.3%
1.74%
-34.2%
BYND SellBEYOND MEAT INC$6,956,000
-39.0%
46,800
-34.1%
1.46%
-34.7%
ENPH SellENPHASE ENERGY INC$6,558,000
+19.9%
295,000
-1.7%
1.38%
+28.6%
DXCM SellDEXCOM INC$6,268,000
-19.5%
42,000
-19.2%
1.32%
-13.7%
DIS SellDISNEY WALT CO$6,255,000
-26.6%
48,000
-21.3%
1.32%
-21.3%
HEIA SellHEICO CORP NEWcl a$6,033,000
-24.2%
62,000
-19.5%
1.27%
-18.7%
EPAM SellEPAM SYS INC$5,469,000
-14.6%
30,000
-18.9%
1.15%
-8.5%
NBIX SellNEUROCRINE BIOSCIENCES INC$5,136,000
-6.4%
57,000
-12.3%
1.08%
+0.3%
ANET SellARISTA NETWORKS INC$4,301,000
-40.8%
18,000
-35.7%
0.90%
-36.6%
PLAN SellANAPLAN INC$4,042,000
-28.5%
86,000
-23.2%
0.85%
-23.3%
CHRS SellCOHERUS BIOSCIENCES INC$3,758,000
-19.0%
185,500
-11.7%
0.79%
-13.3%
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$3,170,000
-35.9%
76,000
-32.7%
0.67%
-31.3%
PTLA SellPORTOLA PHARMACEUTICALS INC$2,521,000
-7.1%
94,000
-6.0%
0.53%
-0.4%
ASND SellASCENDIS PHARMA A Ssponsored adr$2,408,000
-49.0%
25,000
-39.0%
0.51%
-45.3%
GLPG SellGALAPAGOS NVspon adr$1,832,000
-25.2%
12,000
-36.8%
0.39%
-19.8%
MRTX SellMIRATI THERAPEUTICS INC$1,792,000
-63.0%
23,000
-51.1%
0.38%
-60.4%
NYT SellNEW YORK TIMES COcl a$1,538,000
-68.6%
54,000
-64.0%
0.32%
-66.3%
ZM SellZOOM VIDEO COMMUNICATIONS INcl a$1,523,000
-53.6%
20,000
-45.9%
0.32%
-50.2%
PTCT SellPTC THERAPEUTICS INC$853,000
-74.7%
25,208
-66.4%
0.18%
-72.9%
VAC SellMARRIOTT VACTINS WORLDWID CO$207,000
-96.2%
2,000
-96.4%
0.04%
-95.8%
ALLK ExitALLAKOS INCput$0-22,500
-100.0%
-0.19%
RCKT ExitROCKET PHARMACEUTICALS INC$0-102,600
-100.0%
-0.30%
MOH ExitMOLINA HEALTHCARE INC$0-12,000
-100.0%
-0.34%
RARE ExitULTRAGENYX PHARMACEUTICAL IN$0-28,000
-100.0%
-0.35%
ATEX ExitPDVWIRELESS INC$0-38,000
-100.0%
-0.35%
VAR ExitVARIAN MED SYS INC$0-19,000
-100.0%
-0.51%
CTLT ExitCATALENT INCcall$0-50,000
-100.0%
-0.53%
ASH ExitASHLAND GLOBAL HLDGS INC$0-38,000
-100.0%
-0.60%
ARQL ExitARQULE INC$0-317,000
-100.0%
-0.69%
BCO ExitBRINKS CO$0-47,000
-100.0%
-0.75%
GOOS ExitCANADA GOOSE HOLDINGS INC$0-100,000
-100.0%
-0.76%
GH ExitGUARDANT HEALTH INC$0-47,000
-100.0%
-0.80%
SQ ExitSQUARE INCcl a$0-57,000
-100.0%
-0.81%
GWPH ExitGW PHARMACEUTICALS PLCcall$0-25,000
-100.0%
-0.85%
TWLO ExitTWILIO INCcl a$0-32,000
-100.0%
-0.86%
ADVM ExitADVERUM BIOTECHNOLOGIES INC$0-369,000
-100.0%
-0.86%
IOVA ExitIOVANCE BIOTHERAPEUTICS INC$0-185,000
-100.0%
-0.89%
WORK ExitSLACK TECHNOLOGIES INC$0-129,000
-100.0%
-0.95%
CRWD ExitCROWDSTRIKE HLDGS INCcl a$0-77,000
-100.0%
-1.03%
SAGE ExitSAGE THERAPEUTICS INC$0-38,500
-100.0%
-1.38%
GWPH ExitGW PHARMACEUTICALS PLCads$0-54,000
-100.0%
-1.83%
SRPT ExitSAREPTA THERAPEUTICS INC$0-92,000
-100.0%
-2.75%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2019-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MARTIN MARIETTA MATLS INC38Q3 20236.1%
NETFLIX INC35Q2 20235.6%
MICROSOFT CORP32Q3 20236.7%
AMAZON COM INC29Q3 20238.6%
LIBERTY MEDIA CORP DELAWARE29Q2 20235.3%
META PLATFORMS INC25Q3 20235.8%
INTUITIVE SURGICAL INC24Q3 20233.3%
ARGENX SE23Q3 20231.6%
INSPIRE MED SYS INC22Q3 20235.1%
EPAM SYS INC22Q3 20221.8%

View Atika Capital Management LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-14
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-11
13F-HR2021-11-12

View Atika Capital Management LLC's complete filings history.

Compare quarters

Export Atika Capital Management LLC's holdings